VIRIDIAN THERAPEUTICS
Viridian Therapeutics provides treatments for patients with diseases that are underserved by therapies. They develops product candidates to treat patients who suffer from thyroid eye disease, a debilitating orphan disease, and early-stage programs focused on targets and indications.
VIRIDIAN THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2007-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.viridiantherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 272 4600
Email Addresses:
[email protected]
Total Funding:
681.7 M USD
Technology used in webpage:
Google Maps Amazon Mobile Non Scaleable Content HSTS IPv6 ReCAPTCHA Google Maps API Apple Mobile Web App Capable Amazon Virginia Region Ruby On Rails Token
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-28 | Viridian Therapeutics | Viridian Therapeutics acquired by Viridian Therapeutics | N/A |
| 2016-11-02 | Signal Genetics | Signal Genetics acquired by Viridian Therapeutics | 60 M USD |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Viridian Therapeutics
Remeditex Ventures
Remeditex Ventures investment in Series C - Viridian Therapeutics
Fidelity
Fidelity investment in Series C - Viridian Therapeutics
Atlas Venture
Atlas Venture investment in Series C - Viridian Therapeutics
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series C - Viridian Therapeutics
Brace Pharma
Brace Pharma investment in Series C - Viridian Therapeutics
JAFCO
JAFCO investment in Series C - Viridian Therapeutics
Boulder Ventures
Boulder Ventures investment in Series C - Viridian Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Series C - Viridian Therapeutics
Remeditex Ventures
Remeditex Ventures investment in Series B - Viridian Therapeutics
Key Employee Changes
Official Site Inspections
http://www.viridiantherapeutics.com Semrush global rank: 3.07 M Semrush visits lastest month: 5.05 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Viridian Therapeutics"
Viridian - Framing the future of autoimmune diseases
Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditionsSee details»
Our Company - Viridian Therapeutics, Inc.
Sep 11, 2023 · At Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team’s expertise in antibody discovery and engineering, we have created …See details»
Leadership - Viridian Therapeutics, Inc.
Sep 11, 2023 · Steve Mahoney is Viridian’s President and Chief Executive Officer and a member of the Board of Directors. Steve has more than two decades of experience in a variety of operational, financial, commercial, legal and …See details»
Viridian Therapeutics, Inc. - Investors & Media
Sep 11, 2024 · Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.See details»
Viridian Therapeutics, Inc. | LinkedIn
Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.See details»
Viridian Therapeutics, Inc. - Viridian Therapeutics Highlights …
Feb 27, 2024 · WALTHAM, Mass.-- (BUSINESS WIRE)-- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in …See details»
Viridian Therapeutics, Inc. - Viridian Therapeutics Announces …
Sep 10, 2024 · WALTHAM, Mass.-- (BUSINESS WIRE)-- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best …See details»
Patient Community - Viridian Therapeutics, Inc.
Viridian is focused on engineering and developing potential best-in-class medicines for people living with autoimmune and rare diseases.See details»
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial ...
Jul 10, 2023 · Viridian plans to initiate the THRIVE-2 Phase 3 trial to evaluate the safety and efficacy of VRDN-001 in patients with chronic TED in the third quarter of 2023. The Company …See details»
Viridian Therapeutics Announces First Patient Enrolled in
WALTHAM, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best …See details»
miRagen Therapeutics Announces Company Name Change to …
Jan 19, 2021 · Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered …See details»
Viridian Therapeutics Highlights Recent Progress and Reports First ...
WALTHAM, Mass., May 08, 2024--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious …See details»
Join Our Team - Viridian Therapeutics, Inc.
We invite you to browse our open positions and apply for one today. Viridian celebrates individuality – valuing attitude, aptitude, and creativity as highly as skill.See details»
Viridian Therapeutics, Inc. (VRDN) Stock Price, News, Quote
Find the latest Viridian Therapeutics, Inc. (VRDN) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
miRagen Therapeutics Announces Company Name Change to
Jan 19, 2021 · Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most …See details»
Viridian Therapeutics, Inc. - Viridian Therapeutics Announces ...
Jul 25, 2024 · WALTHAM, Mass.-- (BUSINESS WIRE)-- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in …See details»
Viridian Announces Positive Data from Ongoing Phase 1/2
WALTHAM, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from …See details»
Viridian Therapeutics Highlights Recent Progress and Reports …
Feb 27, 2024 · WALTHAM, Mass. -- (BUSINESS WIRE)-- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in …See details»
VRDN Stock Price Quote | Morningstar
Nov 19, 2024 · Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid …See details»
miRagen Therapeutics, Inc. Announces Acquisition of Viridian ...
Oct 28, 2020 · BOULDER, Colo. and WALTHAM, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (“miRagen”) (NASDAQ: MGEN) today announced it has …See details»